SCHEMBL5899565

SCHEMBL5899565

NCC1(C(=O)O)CC1(COCc1ccccc1)COCc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.40
TACR1 P25103 1/20 0.38
SLC1A1 P43005 3/20 0.38
KMT2A Q03164 3/20 0.38
SLC1A3 P43003 2/20 0.38
SLC1A2 P43004 2/20 0.38
CYP2C19 P33261 2/20 0.38
MEN1 O00255 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
ALDH1A1 P00352 3/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
KDM4E B2RXH2 1/20 0.36
POLB P06746 1/20 0.36
GRM5 P41594 1/20 0.36
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SLC6A2 P23975 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899732 0.86 ALDH1A1 (0.40) TSHRSLC1A1KMT2ASLC1A3SLC1A2
SCHEMBL5899733 0.83 EPHX2 (0.41) TSHRSLC1A1KMT2ASLC1A3SLC1A2
SCHEMBL29345920 0.75 TSHR (0.45) TSHRTACR1KDM4EPOLBMAOB
SCHEMBL8000886 0.74 TSHR (0.48) TSHRTACR1SLC1A1KMT2ASLC1A3
SCHEMBL21496636 0.71 TACR1 (0.51) TSHRTACR1SLC1A1KMT2ASLC1A3
SCHEMBL24837580 0.70 TSHR (0.47) TSHRTACR1KDM4EPOLBGRM5
SCHEMBL31450118 0.70 TSHR (0.47) TSHRTACR1KDM4EPOLBGRM5
SCHEMBL25212600 0.70 TSHR (0.47) TSHRTACR1KDM4EPOLBGRM5
SCHEMBL25210438 0.70 TSHR (0.47) TSHRTACR1KDM4EPOLBGRM5
SCHEMBL4154204 0.69 TACR1 (0.49) TSHRTACR1SLC1A1KMT2ASLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030267-B2 Cycloproply β-amino acid derivatives WARNER-LAMBERT COMPANY, LLC (US) 2006-04-18 US disclosed
US-20040147608-A1 Cyclopropyl beta-amino acid derivatives SCHWARZ JACOB BRADLEY (US) 2004-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147608-A1 Cyclopropyl beta-amino acid derivatives CACNA1S, CACNA1D, CACNA1B TSHR 2379/4885TACR1 250/4885SLC1A1 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.